>

>

Choice of an initial antiretroviral regimen in the resource-limited setting: the cost of virologic failure

Campbell, T.B.

Clinical Infectious Diseases An Official Publication of the Infectious Diseases Society of America 47(5): 723-725

2008

ISSN/ISBN: 1537-6591

PMID: 18662135

DOI: 10.1086/590944

Document Number: 206037

Document emailed within 0-6 h

Kalyesubula, R.; Kagimu, M.; Opio, K.C.; Kiguba, R.; Semitala, C.F.; Schlech, W.F.; Katabira, E.T. 2011: Hepatotoxicity from first line antiretroviral therapy: an experience from a resource limited setting African Health Sciences 11(1): 16-23

Kim, L.H.; Cohan, D.L.; Sparks, T.N.; Pilliod, R.A.; Arinaitwe, E.; Caughey, A.B. 2013: The cost-effectiveness of repeat HIV testing during pregnancy in a resource-limited setting Journal of Acquired Immune Deficiency Syndromes 63(2): 195-200

Havers, F.P.; Detrick, B.; Cardoso, S.W.; Berendes, S.; Lama, J.R.; Sugandhavesa, P.; Mwelase, N.H.; Campbell, T.B.; Gupta, A. 2014: Change in vitamin d levels occurs early after antiretroviral therapy initiation and depends on treatment regimen in resource-limited settings Plos one 9(4): E95164

Haberer, J.E.; Kiwanuka, J.; Nansera, D.; Wilson, I.B.; Bangsberg, D.R. 2010: Challenges in using mobile phones for collection of antiretroviral therapy adherence data in a resource-limited setting Aids and Behavior 14(6): 1294-1301

Bendavid, E.; Wood, R.; Katzenstein, D.A.; Bayoumi, A.M.; Owens, D.K. 2009: Expanding antiretroviral options in resource-limited settings--a cost-effectiveness analysis Journal of Acquired Immune Deficiency Syndromes 52(1): 106-113

Kitkungvan, D.; Apisarnthanarak, A.; Laowansiri, P.; Mundy, L.M. 2008: Secure antiretroviral therapy delivery in a resource-limited setting: streamlined to minimize drug resistance and expense HIV Medicine 9(8): 636-641

Berhan, Y. 2011: Change in absolute CD4 count with antiretroviral treatment in resource limited setting: a retrospective cohort study in children in Ethiopia Ethiopian Medical Journal 49(4): 289-298

Penda, C.I.; Bebey, F.S.; Mangamba, D.K.; Moukoko, E.C.E.; Ngwa, V.; Makouet, N.; Bissek, A.-C.éc.; Minkemdefo, B.D.; Tetanye, E.; Ndombo, P.K. 2013: Treatment failure in children infected with HIV in routine follow-up in a resource-limited setting in Cameroon Pan African Medical Journal 15: 80

Kumarasamy, N.; Venkatesh, K.K.; Devaleenol, B.; Saghayam, S.; Manohar, D.; Poongulali, S.; Yepthomi, T.; Ambrose, P.; Solomon, S.; Mayer, K.H. 2010: Safe substitution to zidovudine among HIV-infected patients initiated on stavudine-containing highly active antiretroviral therapy from a resource-limited setting International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 13(6): E360-E364

Macpherson, P.; Lalloo, D.G.; Thindwa, D.; Webb, E.L.; Squire, S.B.; Chipungu, G.A.; Desmond, N.; Makombe, S.D.; Taegtmeyer, M.; Choko, A.T.; Corbett, E.L. 2014: A novel community health worker tool outperforms WHO clinical staging for assessment of antiretroviral therapy eligibility in a resource-limited setting Journal of Acquired Immune Deficiency Syndromes 65(2): E74-E78

Crawford, K.W.; Ripin, D.H.Brown.; Levin, A.D.; Campbell, J.R.; Flexner, C.; Cooper, D.; Emery, S.; Amogne, W.; Gidada, B.Gudetta.; Sanne, I.; Maartens, G.; McIlleron, H.; Lee, J.; Essajee, S.; Back, D.J.; Hill, A.; Becker, S.; Shaffer, K.; Cue, B.; Rakhmanina, N.; Catlin, K.; Ellis, D.; Ripin, D.; Singh, I.; Staple, A.; Liotta, D.; Fortunak, J.; Crawford, K.W.; Doherty, M.; Flexner, C.; Greenhalgh, M.; Ruff, A.; Kim, P.; Anderson, N.; Byrn, S.; Smith, D.; Morgan, S.; Blaschke, T.; Savic, R.; Dagger, R.E.; Barnhart, M.; Saag, M.; Morse, G.; Fle 2012: Optimising the manufacture, formulation, and dose of antiretroviral drugs for more cost-efficient delivery in resource-limited settings: a consensus statement Lancet. Infectious Diseases 12(7): 550-560

Gerlach, J.; Sequeira, M.; Alvarado, V.; Cerpas, C.; Balmaseda, A.; Gonzalez, A.; de Los Santos, T.; Levin, C.E.; Amador, J.J.; Domingo, G.J. 2010: Cost analysis of centralized viral load testing for antiretroviral therapy monitoring in Nicaragua, a low-HIV prevalence, low-resource setting Journal of the International Aids Society 13: 43

Harries, A.D.; Zachariah, R.; van Oosterhout, J.J.; Reid, S.D.; Hosseinipour, M.C.; Arendt, V.; Chirwa, Z.; Jahn, A.; Schouten, E.J.; Kamoto, K. 2010: Diagnosis and management of antiretroviral-therapy failure in resource-limited settings in sub-Saharan Africa: challenges and perspectives LANCET. Infectious Diseases 10(1): 60-65

Kantor, R.; Diero, L.; Delong, A.; Kamle, L.; Muyonga, S.; Mambo, F.; Walumbe, E.; Emonyi, W.; Chan, P.; Carter, E.J.; Hogan, J.; Buziba, N. 2009: Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 49(3): 454-462

Oyugi, J.H.; Byakika-Tusiime, J.; Charlebois, E.D.; Kityo, C.; Mugerwa, R.; Mugyenyi, P.; Bangsberg, D.R. 2004: Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting Journal of Acquired Immune Deficiency Syndromes 36(5): 1100-1102

Koethe, J.R.; Marseille, E.; Giganti, M.J.; Chi, B.H.; Heimburger, D.; Stringer, J.S. 2014: Estimating the cost-effectiveness of nutrition supplementation for malnourished, HIV-infected adults starting antiretroviral therapy in a resource-constrained setting Cost Effectiveness and Resource Allocation: C/E 12: 10

Vreeman, R.C.; Nyandiko, W.M.; Ayaya, S.O.; Walumbe, E.G.; Marrero, D.G.; Inui, T.S. 2010: The perceived impact of disclosure of pediatric HIV status on pediatric antiretroviral therapy adherence, child well-being, and social relationships in a resource-limited setting Aids Patient Care and Stds 24(10): 639-649

Nachega, J B; Mills, E J 2007: Antiretroviral therapy adherence in resource-limited and resource-rich settings: current status of knowledge and research priorities Therapy 4(6): 775-786

Newman, H.; Breunig, L.; van Zyl, G.; Stich, A.; Preiser, W. 2014: A qualitative PCR minipool strategy to screen for virologic failure and antiretroviral drug resistance in South African patients on first-line antiretroviral therapy Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 60(4): 387-391

Walensky, R.P.; Wolf, L.L.; Wood, R.; Fofana, M.O.; Freedberg, K.A.; Martinson, N.A.; Paltiel, A.D.; Anglaret, X.; Weinstein, M.C.; Losina, E.; Messou, E.èn.; Seyler, C.; Touré, S.; Yazdanpanah, Y.; Kumarasamy, N.; Ganesh, J.; Ganesh, A.K.; Gray, G.; McIntyre, J.; Mohapi, L.; Cotich, K.; Goldie, S.; Horsburgh, C.R.; Kimmel, A.; Lipsitch, M.; McCormick, A.; Rydzak, C.; Seage, G.R.; Zhang, H.; Hsu, H.E.; Bassett, I.V.; Bender, M.A.; Chung, S.; Ciaranello, A.; Linas, B.P.; Lu, Z.; Morris, B.; Saxena, A.; Sloan, C.; Uhler, L.; Wang, B. 2009: When to start antiretroviral therapy in resource-limited settings Annals of Internal Medicine 151(3): 157-166